Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

APPETITE SUPPRESSANT DRUG COVERAGE RATE DECLINES TO 16% OF LARGE EMPLOYERS IN 1996, PBMI SURVEY FINDS; HMOs, PBMs SEE IMPACT OF DTC ADS FOR DRUGS -- NOVARTIS

Executive Summary

Appetite suppressant drugs are covered by just 16% of large employers surveyed by the Pharmacy Benefit Management Institute, PBMI's recently-released Prescription Drug Benefit Cost & Plan Design Survey Report states.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030457

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel